Liposomal ciprofloxacin: Completed Phase III enrollment

Aradigm completed enrollment of 304 patients with a history of pulmonary exacerbations and chronic Pseudomonas aeruginosa infections in the international Phase III ORBIT-4 trial of inhaled Pulmaquin. ...